259 completed, 54 terminated, 36 recruiting, 22 not yet recruiting. 161 Phase 2, 115 Phase 1, 108 Phase 3, 39 Phase 4, 28 Not applicable.
Follow Matching Placebo: new trials by email Literature Review of Matching Placebo trials Research Report on Matching Placebo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Trial of FT2109 for the Treatment of Psoriatic Arthritis FT2109 Dosing Regimen 1, FT2109 Dosing Regimen 2, Matching Placebo - Psoriatic Arthritis (PsA) | Phase 2 | Not yet recruiting | Forward Therapeutics | 210 | 2026-12-01 | 2026-10-09 |
| HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting Semaglutide Calcium-HMB Plus Vitamin D3, Matching placebo - Type 2 Diabetes Mellitus (T2DM), Sarcopenia | Phase 2 | Not yet recruiting | Vanderbilt University Medical Center | 90 | 2026-12-01 | 2026-08-28 |
| Urolithin A and Its Effects on Attention and Sleep Timing in Healthcare Workers After Night Shifts Urolithin A(StanYouth™️ Urolithin A), Matching Placebo - Attention, Sleep, and Circadian Rhythms After Night Shifts in Healthcare Workers | Not applicable | Not yet recruiting | Liangkai Chen | 40 | 2026-11-16 | 2026-11-19 |
| Suzetrigine for Analgesiain Arthroscopic Rotator Cuff Repair Suzetrigine (Journavx), Matching placebo, Standard multimodal analgesia - Artroscopic Surgery, Pain Management | Phase 4 | Not yet recruiting | University of Alabama at Birmingham | 100 | 2026-11-01 | 2026-10-08 |
| Tizanidine Premedication Versus Placebo for Laryngeal Mask Airway Insertion and Recovery in Adults Undergoing Ambulatory Surgery Tizanidine, Placebo - Airway Management | Not applicable | Not yet recruiting | Beni-Suef University | 110 | 2026-11-01 | 2026-11-06 |
| Coronary MicrovAscular Diseases Intervention With Compound Danshen Dropping Pills Compound Danshen Dripping Pills, Placebo - Coronary Microvascular Disease | Phase 4 | Recruiting | Qilu Hospital of Shandong University | 496 | 2026-11-01 | 2026-11-18 |
| Perioperative Mirogabalin for Pain Relief After Modified Radical Mastectomy Mirogabalin, Placebo - Breast Cancer, Post Operative Pain | Not applicable | Not yet recruiting | Cairo University | 50 | 2026-10-15 | 2026-10-19 |
| Unflavored Powdered Multivitamin in Children EllaOla Kids Essentials Unflavored Powdered Multivitamin, Placebo (Tapioca Fiber) - Selective Eating, Emotional Dysregulation | Not applicable | Not yet recruiting | EllaOla | 166 | 2026-10-14 | 2026-10-13 |
| Probiotic Trial for URTI Prevention in Healthy Adults Probiotic Formula, Matching placebo - Upper Respiratory Tract Infections | Not applicable | Recruiting | Harokopio University | 140 | 2026-10-01 | 2026-11-02 |
| A Study of IBI3042 in Healthy Adult Participants Investigational Drug: IBI3042, Matching Placebo - Healthy Volunteers (HV) | Phase 1 | Not yet recruiting | Fortvita Biologics (USA)Inc. | 32 | 2026-09-29 | 2026-09-25 |
| Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis Metformin, Matching Placebo - Idiopathic Pulmonary Fibrosis | Phase 3 | Not yet recruiting | University of Massachusetts, Worcester | 800 | 2026-09-28 | 2026-09-08 |
| A Phase 2 Study of MG-K10 in Chronic Spontaneous Urticaria MG-K10 Injection, Matching Placebo - Chronic Urticaria, Idiopathic | Phase 2 | Not yet recruiting | Shanghai Mabgeek Biotech.Co.Ltd | 60 | 2026-09-23 | 2026-09-24 |
| Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD) 611, Matching placebo - Dermatitis, Atopic | Phase 3 | Recruiting | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 246 | 2026-09-22 | 2026-10-09 |
| Phase 1b Clinical Study in Patients With Active Ulcerative Colitis TP317, Matching placebo - Ulcerative Colitis (UC) | Phase 1 | Not yet recruiting | Thetis Pharmaceuticals LLC | 24 | 2026-09-16 | 2026-09-22 |
| IBI3042 Study in Healthy Participants and Overweight or Obese Participants Orforglipron, Matching Placebo, IBI3042 - Overweight, Healthy Participants | Phase 1 | Recruiting | Innovent Biologics (Suzhou) Co. Ltd. | 104 | 2026-09-07 | 2026-09-11 |
| A Study of Probiotics in Patients With Acute Ischemic Stroke probiotic supplement OMNi-BiOTiC® SR-9, Matching Placebo - Ischemic Stroke | Phase 2 | Not yet recruiting | Capital Medical University | 220 | 2026-09-01 | 2026-06-17 |
| Safety and Efficacy of AV078 in Participants With Tuberous Sclerosis Complex (TSC) Refractory Epilepsy (RESTOR-1) AV078, Placebo - Tuberous Sclerosis Complex, Epilepsy | Phase 2 | Not yet recruiting | Aeovian Pharmaceuticals, Inc. | 42 | 2026-09-01 | 2026-09-29 |
| Safety of NRICM301 Added to Standard Care in Adults With Acute Ischemic Stroke NRICM301, Matching Placebo - Acute Ischemic Stroke | Not applicable | Not yet recruiting | Tri-Service General Hospital (TSGH) | 45 | 2026-09-01 | 2026-10-29 |
| Single Ascending Dose Study of ACC085 Injection in Healthy Chinese Adults Matching Placebo - Healthy Adult Participants | Phase 1 | Recruiting | Jiangsu Aidea Pharmaceutical Group Co., Ltd. | 47 | 2026-08-31 | 2026-09-25 |
| The Therapeutic Effects of Ceylon Cinnamon Supplementation and a Self-Efficacy Educational Program on Glycemic Control, Lipid Profiles, and Pain in Type 2 Diabetes Mellitus With Painful Diabetic Peripheral Neuropathy Ceylon Cinnamon (Cinnamomum verum) Supplement, Matching Placebo, Self-Efficacy-Based Educational Program - Type 2 Diabetes Mellitus, Painful Diabetic Peripheral Neuropathy (PDPN) | Not applicable | Not yet recruiting | Jerash Private University | 900 | 2026-08-01 | 2026-08-11 |
Showing 20 of 424. Sign in to see all of them.
Asthma (13) · Obesity (11) · Pain (11) · Amyotrophic Lateral Sclerosis (10) · Diabetes Mellitus, Type 2 (10) · Alzheimer Disease (9) · Attention Deficit Disorder with Hyperactivity (8) · COVID-19 (8) · Cardiovascular Diseases (8) · Dermatitis, Atopic (8) · Migraine Disorders (7) · Schizophrenia (7) · Arthritis, Rheumatoid (6) · Inflammation (6) · Ischemic Stroke (6)
Regeneron Pharmaceuticals (24) · Boehringer Ingelheim (9) · Ironwood Pharmaceuticals, Inc. (9) · Celldex Therapeutics (8) · GlaxoSmithKline (8) · Merit E. Cudkowicz, MD (8) · AstraZeneca (7) · Bayer (7) · Mallinckrodt (7) · Grünenthal GmbH (5) · Merck Sharp & Dohme LLC (5) · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (5) · Viatris Innovation GmbH (5) · Cognition Therapeutics (4) · Hoffmann-La Roche (4)
United States (234) · Canada (63) · Germany (60) · United Kingdom (47) · Poland (46) · Spain (44) · Australia (42) · France (40) · China (37) · Netherlands (36) · Italy (35) · Belgium (29) · Japan (23) · Hungary (19) · Israel (19)
Merit Cudkowicz, MD (6) · Connie Celum, MD, MPH (3) · Ivan Fan-ngai Hung (3) · Adam Boxer, MD, PhD (2) · Anne-Marie Wills, MD (2)
PMID 11112243, PMID 16135345, PMID 17175134, PMID 18662331, PMID 19453963, PMID 20548058, PMID 22338037, PMID 22520687, PMID 23661689, PMID 25744676, PMID 26603732, PMID 27206567, PMID 27659698, PMID 27888609, PMID 28322750, PMID 29310498, PMID 33540241, PMID 33687069, PMID 34768178, PMID 35142535, PMID 39588375, PMID 40434633, PMID 40993471, PMID 42779129, PMID 18008230, PMID 18804555, PMID 18928378, PMID 19169140, PMID 19236277, PMID 19236279, PMID 19238149, PMID 19761871, PMID 19935017, PMID 19996872, PMID 20045700, PMID 20052461, PMID 20124229, PMID 20375406, PMID 20427778, PMID 20707784, PMID 20801122, PMID 20949623, PMID 21471141, PMID 21521847, PMID 21690488, PMID 21795446, PMID 21830967, PMID 22082672, PMID 22104981, PMID 22128201
2019 (13), 2017 (11), 2023 (8), 2016 (6), 2018 (4), 2008 (3), 2014 (3), 2025 (3), R01AG085029 (2), 2009 (1), 2015 (1), P30CA012197 (1), P30DK056350 (1), R01AG024154 (1), R01AG058660 (1)